Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 4/20 | 0.46 |
| ▸ | CA2 | P00918 | 4/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | PDCD1 | Q15116 | 8/20 | 0.44 |
| ▸ | CD274 | Q9NZQ7 | 8/20 | 0.44 |
| ▸ | CA9 | Q16790 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 0.43 |
| ▸ | MPO | P05164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1741412 | 1.00 | POLB (0.49) | POLBMAPK1HIF1ATSHRCYP2D6 | |
| SCHEMBL3679027 | 0.87 | PDCD1 (0.45) | PDCD1CD274 | |
| SCHEMBL17223893 | 0.87 | PDCD1 (0.45) | PDCD1CD274 | |
| SCHEMBL28567356 | 0.85 | AKR1B1 (0.50) | POLBMAPK1HIF1ATSHRCYP2D6 | |
| SCHEMBL6234672 | 0.84 | POLB (0.61) | POLBMAPK1HIF1ATSHRCYP2D6 | |
| SCHEMBL2878063 | 0.84 | POLB (0.47) | POLBMAPK1HIF1ATSHRCYP2D6 | |
| SCHEMBL2878055 | 0.84 | POLB (0.47) | POLBMAPK1HIF1ATSHRCYP2D6 | |
| SCHEMBL2985297 | 0.84 | MPO (0.47) | AKR1B1CA12CA2PDCD1CD274 | |
| SCHEMBL11813050 | 0.83 | MEN1 (0.50) | POLBMAPK1HIF1ATSHRCYP2D6 | |
| SCHEMBL13093374 | 0.83 | TSHR (0.44) | POLBMAPK1HIF1ATSHRCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2340823-B1 | IRON CHELATING AGENT, METHOD FOR PRODUCING THE SAME, METHOD FOR DETERMINING AMOUNT OF IRON IONS AND METHOD FOR TRAPPING IRON IONS | NAT UNIVERSITY CORP ASAHIKAWA MEDICAL COLLEGE (JP) | 2016-02-10 | — | — | EP | disclosed |
| US-8623661-B2 | Iron chelating agent, method for producing same, method for determining amount of iron ions and method for trapping iron ions | NATIONAL UNIVERSITY CORPORATION ASAHIKAWA MEDICAL COLLEGE (JP) | 2014-01-07 | — | — | US | disclosed |
| US-8623661-B2 | Iron chelating agent, method for producing same, method for determining amount of iron ions and method for trapping iron ions | NATIONAL UNIVERSITY CORPORATION ASAHIKAWA MEDICAL COLLEGE (JP) | 2014-01-07 | — | — | US | disclosed |
| US-8623661-B2 | Iron chelating agent, method for producing same, method for determining amount of iron ions and method for trapping iron ions | NATIONAL UNIVERSITY CORPORATION ASAHIKAWA MEDICAL COLLEGE (JP) | 2014-01-07 | — | — | US | disclosed |
| US-20110189779-A1 | IRON CHELATING AGENT, METHOD FOR PRODUCING SAME, METHOD FOR DETERMINING AMOUNT OF IRON IONS AND METHOD FOR TRAPPING IRON IONS | YAMAGATA UNIVERSITY (JP) | 2011-08-04 | — | — | US | disclosed |
| US-20110189779-A1 | IRON CHELATING AGENT, METHOD FOR PRODUCING SAME, METHOD FOR DETERMINING AMOUNT OF IRON IONS AND METHOD FOR TRAPPING IRON IONS | YAMAGATA UNIVERSITY (JP) | 2011-08-04 | — | — | US | disclosed |
| US-20110189779-A1 | IRON CHELATING AGENT, METHOD FOR PRODUCING SAME, METHOD FOR DETERMINING AMOUNT OF IRON IONS AND METHOD FOR TRAPPING IRON IONS | YAMAGATA UNIVERSITY (JP) | 2011-08-04 | — | — | US | disclosed |
| EP-2340823-A1 | IRON CHELATING AGENT, METHOD FOR PRODUCING SAME, METHOD FOR DETERMINING AMOUNT OF IRON IONS AND METHOD FOR TRAPPING IRON IONS | National University Corporation Asahikawa Medical College (JP) | 2011-07-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110189779-A1 | IRON CHELATING AGENT, METHOD FOR PRODUCING SAME, METHOD FOR DETERMINING AMOUNT OF IRON IONS AND METHOD FOR TRAPPING IRON IONS | SLC40A1, FTH1, TFRC | POLB 3330/4885MAPK1 4652/4885HIF1A 544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.